Drugs / TTP4000
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01548430 | Oct 2011 → Feb 2013 | Alzheimer disease | vTv Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TTP4000 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01548430 ↗ |
| Route | Subcutaneous | “Administered subcutaneously” NCT01548430 ↗ |